MedPath

to study the efficacy of Modified Roudra Rasa in Cancer

Phase 3
Conditions
Health Condition 1: C227- Other specified carcinomas of liver
Registration Number
CTRI/2021/09/036173
Lead Sponsor
Indian institute of Ayurveda Research Hospital Rajkot
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

ECOG- score 0-3

Metastatic cancer in Liver with primary in any of the following organs.

Breast, Prostate, Head and Neck Cancer, Rectum, ovary, uterus, intestine, pancreas.

Patients would have received conventional treatment, be it, surgery, radiation, chemotherapy and immunotherapy and failed. That is progressive disease despite conventional therapeutics.

Exclusion Criteria

Patient with:

Performance status more than ECOG3.

Patients with metastasis in brain.

Patients with skeletal fractures or metal implements.

Informed consent not given.

8.H/O. stroke, Primary or metastatic brain tumour.

Multi organ failure.

Cirrhosis or chronic-renal disease.

Pregnancy.

H/O. Convulsions.

Uncorrected dehydration.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Relief in the associated signs and symptoms and improvement in the physical and mental state of the patients.Timepoint: after 1 year of treatment Relief in the associated signs and symptoms and improvement in the physical and mental state of the patients.
Secondary Outcome Measures
NameTimeMethod
Complete subsidence of the presenting complaints with negative biopsy.Timepoint: 6 months
© Copyright 2025. All Rights Reserved by MedPath